- News article -

Spinverse strengthens its EU project portfolio in Life Sciences with PeptiCaps

19 Nov 2015

The PeptiCaps project develops a novel nanotechnology for the delivery of specific active ingredients in skin care application.

Safe and efficient nanocapsules releasing active ingredients in response to certain skin conditions, such as allergic contact dermatitis, skin irritations, sun damage and pigmentation problems, are set to become reality in the PeptiCaps project.

The “smart” nanocapsules developed in the project will be designed to respond to changes in pH and enzyme secretion in the affected skin area, delivering the active ingredients where and when the skin conditions occur. Their effectiveness will be validated by comparing them with equivalent products that do not respond to stimuli.

Given the growing public and academic concern regarding the safety, health risks and ecotoxicity of engineered nanomaterials, the project will also study these aspects of the products that are developed in accordance with the guidelines set by the OECD.

This EU-funded project, coordinated by Spanish IK4-CIDETEC, combines the expertise of nine European organisations from five different countries, 4 companies and 5 research centers. Spinverse already participated in the preparation of the proposal, helping in ensuring the funding of €3,85 million for the 3-year project with excellent evaluation scores. During the project itself, Spinverse will take part by creating and developing the business plan for the novel nanocapsules, and supporting the project’s exploitation and dissemination efforts.

With Pepticaps, Spinverse strenghtens further its expertise in Life Sciences

Spinverse has already broadened its portfolio of projects within health and biotech sectors as demonstrated by its recent examples of successful projects in the field of biotech and health/pharma sectors:

  • NanoPilot, where Spinverse helped in securing €6.3 million in EU funding for a pilot plant to produce polymer-based nano-pharmaceuticals. During the 4-year project, Spinverse creates the business plan for the plant.
  • IP4Plasma enables industrial innovations based on EU IP assets in plasma technology. The project aims at creating a highly sensitive tuberculosis test to allow diagnosis within minutes at a cost as low as €1 per test, as well as advanced wound dressings. After successfully managing the preparation of the proposal, Spinverse coordinates the project and develops the commercialisation strategy of the technology.
  • APEX project is a MetGen project in which Spinverse provided support in successfully applying for Horizon 2020 SME instrument phase 2 funding. The project aims at the scale-up from pilot to industrial scale production of MetZyme®, an enzyme solution developed by MetGen, and the improvement of the cost-efficiency of the industrial enzyme development.
  • CLEEN/FIBIC BEST. With the expertise in building and managing PPPs, Spinverse helped launch BEST (Sustainable Bioenergy Solutions for Tomorrow) to enable a stronger and more competitive Finnish bioenergy ecosystem.

In order to serve even better its clients in these sectors, Spinverse has also strengthened the number of its professionals during the past 6 months with Riikka Paasikivi and Catherine Bounsaythip joining Spinverse, bringing with them their extensive network and experience in research and business development within health, bio and pharma industries.

- Contact us -

Want to learn more how Spinverse could help you? Contact us now!



Riikka Paasikivi

Senior Consultant, M.Sc. (Chem.Eng.) +358 50 521 5944

- News -

Relevant posts

European Funding Public Funding SME

EWGIC Position Paper: European recovery needs innovation

27 Jul 2020

The European Working Group of Innovation Consultants (EWGIC) has published a new Position Paper regarding th...

EU funding European Defence Fund

Growth opportunities for companies developing defence technologies

13 Jul 2020

In 2017, the European Commission officially launched the European Defence Fund to boost Europe’s defence c...

EU funding Public Funding Horizon Europe

Horizon Europe: growth opportunities for thousands of innovative projects – are you ready for your next step?

9 Jul 2020

Horizon Europe will be launched in January 2021 and extends until 2027. It is the European Commission's prop...

Our People Spinverse News

Congratulations to a new Ph.D. at Spinverse

8 Jul 2020

In July, Spinverse Consultant Sonja Lätti defended her doctoral dissertation on the evolution of innovation...

European Funding Public Funding renewable energy

The first call of the Innovation Fund is now open for proposals to boost greener Europe

6 Jul 2020

The European Commission has just launched the first call for proposals under the Innovation Fund, with over ...

Client News digital healthcare health technology

Healthcare projects within CleverHealth Network are moving forward

29 Jun 2020

The CleverHealth Network ecosystem is buzzing with activity as the ongoing six co-development projects aim t...